Item 5.07 Submission of Matters to a Vote of Security Holders.
On September 30, 2021, Sanara MedTech Inc. (the "Company") held its 2021 Annual
Meeting of Shareholders (the "Annual Meeting"). A total of 5,249,172 shares of
the Company's common stock were present in person or represented by proxy at the
Annual Meeting. The matter submitted for a vote and the related results are set
forth below. A more detailed description of the proposal was included in the
Company's Definitive Proxy Statement on Schedule 14A filed with the Securities
and Exchange Commission (the "SEC") on August 30, 2021, as supplemented by the
Company's Proxy Statement Supplement filed with the SEC on September 13, 2021.
Proposal 1: Election of (i) Ronald T. Nixon, (ii) J. Michael Carmena, (iii)
Robert A. DeSutter, (iv) Sara N. Ortwein, (v) Ann Beal Salamone, (vi) James W.
Stuckert and (vii) Kenneth E. Thorpe to the Company's Board of Directors, each
to serve for a one-year term until the annual meeting of shareholders to be held
in 2022 or until his or her successor is elected and qualified.
Votes Votes
Nominee Cast For Withheld
Ronald T. Nixon 5,248,772 400
J. Michael Carmena 5,246,472 2,700
Robert A. DeSutter 5,226,455 22,717
Sara N. Ortwein 5,246,180 2,992
Ann Beal Salamone 5,246,380 2,792
James W. Stuckert 5,225,820 23,352
Kenneth E. Thorpe 5,226,483 22,689
The proposal described above was acted upon by the Company's shareholders at the
Annual Meeting and received a sufficient number of votes to be approved.
2
© Edgar Online, source Glimpses